Promise Grants

Agency: 
Komen Foundation

Research projects supported by Promise Grants must provide an integrated approach to solving a critical challenge that will lead to the rapid translation of scientific discoveries into new or enhanced clinical tools and applications with the greatest potential to significantly reduce breast cancer incidence and/or mortality within the next decade. Projects must be designed to yield converging evidence that answers an important over-arching problem in breast cancer (e.g., resistance to currently available targeted therapies or novel therapies for triple negative breast cancer). Relevant research applications may include components that focus on breast cancer biology; genetics; epidemiology; prevention; detection; risk assessment; biomarkers of risk, disease burden, and/or treatment response or resistance; novel therapeutics; lifestyle interventions with the potential to affect disease outcomes (e.g., incidence and/or mortality); and novel approaches that enhance understanding of the breast cancer disease process.

Deadline: 
July 26, 2010

Last updated June 25, 2010